Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin for Catheter-Related Gram Positive Bloodstream Infections
NCT00467272Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2007
- Primary completion
- Sep 2012
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daptomycin in catheter-related bloodstream infection (CRBSI), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2007; status: completed.
02
Drugs
daptomycin
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT00467272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467272.